RxDoctor Payments Data

Mary Walter, NP

Psychiatric/Mental Health · Prince Frederick, MDNPI 1023449642

Payments from drug & device makers

$1,280in general payments, 2019–2025

Across 96 payments — averaging $13.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$384
  • AbbVie$295
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$134
  • Alkermes, Inc.$82
  • Vanda Pharmaceuticals Inc.$69
  • Otsuka America Pharmaceutical, Inc.$50
  • plus $266 from 11 others

What the payments were for

  • Food & beverage$1,280100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,280 in reported general payments places this provider in the 75th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland

Medicare billing

Part B allowed, 2024
$36,992
Medicare patients
134
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate11$25,480
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl71$19,692
AuvelityDextromethorphan Hbr/Bupropion11$13,935
Lurasidone Hcl15$9,702
VyvanseLisdexamfetamine Dimesylate11$4,217
Aripiprazole99$4,047
Venlafaxine Hcl ErVenlafaxine Hcl80$3,736
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine56$3,690
Quetiapine Fumarate167$3,051
Clorazepate Dipotassium14$2,176
Fluphenazine Decanoate19$1,694
Olanzapine67$1,379
Hydroxyzine Pamoate122$1,378
Haloperidol Decanoate40$1,354
Oxcarbazepine41$1,296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$43$25,48011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,461 psychiatric/mental health providers in Maryland.

Other psychiatric/mental health in Prince Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →